XML 70 R60.htm IDEA: XBRL DOCUMENT v3.21.2
Business Combinations - Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jun. 19, 2020
Sep. 30, 2021
Dec. 31, 2020
Business Combination Segment Allocation [Line Items]      
Goodwill   $ 61,189 $ 58,632
Progenics      
Business Combination Segment Allocation [Line Items]      
Cash and cash equivalents $ 15,421    
Accounts receivable 5,787    
Inventory 1,075    
Other current assets 3,684    
Property, plant and equipment 14,972    
Identifiable intangible assets IPR&D 151,100    
Other long-term assets 37,631    
Accounts payable (1,616)    
Accrued expenses and other liabilities (8,287)    
Other long-term liabilities (31,158)    
Long-term debt and other borrowings (40,200)    
Deferred tax liabilities (5,975)    
Goodwill 45,475    
Total consideration transferred 419,009    
Progenics | Previously Reported      
Business Combination Segment Allocation [Line Items]      
Cash and cash equivalents 15,421    
Accounts receivable 5,787    
Inventory 915    
Other current assets 3,250    
Property, plant and equipment 14,972    
Identifiable intangible assets IPR&D 150,900    
Other long-term assets 37,631    
Accounts payable (1,616)    
Accrued expenses and other liabilities (8,207)    
Other long-term liabilities (30,778)    
Long-term debt and other borrowings (40,200)    
Deferred tax liabilities (3,717)    
Goodwill 42,051    
Total consideration transferred 419,009    
Progenics | Revision of Prior Period, Adjustment      
Business Combination Segment Allocation [Line Items]      
Inventory 160    
Other current assets 434    
Identifiable intangible assets IPR&D 200    
Accrued expenses and other liabilities (80)    
Other long-term liabilities (380)    
Deferred tax liabilities (2,258)    
Goodwill 3,424    
Total consideration transferred 0    
Currently marketed products | Progenics      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ 142,900    
Identifiable intangible assets useful lives 15 years    
Currently marketed products | Progenics | Previously Reported      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ 142,100    
Currently marketed products | Progenics | Revision of Prior Period, Adjustment      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets 800    
Licenses | Progenics      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ 85,800    
Identifiable intangible assets useful lives 11 years 6 months    
Licenses | Progenics | Previously Reported      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ 87,500    
Licenses | Progenics | Revision of Prior Period, Adjustment      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets (1,700)    
Developed technology | Progenics      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ 2,400    
Identifiable intangible assets useful lives 9 years    
Developed technology | Progenics | Previously Reported      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ 3,000    
Developed technology | Progenics | Revision of Prior Period, Adjustment      
Business Combination Segment Allocation [Line Items]      
Identifiable intangible assets $ (600)